University of Minnesota Department of Medicine
Welcome,         Profile    Billing    Logout  
 3 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mueller, Daniel
CAN-BIND-17, NCT05017311: Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)

Recruiting
4
400
Canada
Escitalopram, Cipralex, Brexpiprazole, Rexulti
Nova Scotia Health Authority, Unity Health Toronto, Centre for Addiction and Mental Health, McMaster University, Queen's University, University of Ottawa, University of British Columbia, University of Calgary, McGill University, Dalhousie University, University of Michigan, Simon Fraser University
Major Depressive Disorder
12/28
04/29
NCT04162522: Canadian Biomarker Integration Network for Depression (CAN-BIND) - Validation Study

Completed
3
1
Canada
Escitalopram, Cipralex, Brexpiprazole, Rexulti
University Health Network, Toronto, Unity Health Toronto, Baycrest, Centre for Addiction and Mental Health, McMaster University, Queen's University, University of Ottawa, University of British Columbia, University of Calgary, McGill University, Dalhousie University, University of Michigan, Simon Fraser University
Major Depressive Disorder
12/22
12/22
NCT02813083: Detection of Pathological Lymphocytes in Patients With Autoimmune Disease

Completed
N/A
129
US
No intervention (observational)
University of Minnesota
Arthritis, Rheumatoid
09/23
09/23
ENABLE, NCT06408012: An Innovative Master Platform for Clinical Trials in Mood Disorders

Recruiting
N/A
900
Canada
St. Joseph's Healthcare Hamilton, Unity Health Toronto, Centre for Addiction and Mental Health, Queen's University, University of Ottawa, University of British Columbia, University of Calgary, McGill University, Nova Scotia Health Authority, University of Michigan, Simon Fraser University, University Health Network, Toronto
Mood Disorders, Depressive Disorder, Bipolar and Related Disorders
03/26
03/26

Download Options